During the past decade, Pima Vascular conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pima Vascular" are "Peripheral Arterial Disease" (2 trials), "Claudication" (1 trials), "Critical Limb Ischemia" (1 trials), "Infrainguinal Peripheral Artery Disease" (1 trials) and "PAD" (1 trials). Many other conditions were trialed in "Pima Vascular" in a lesser frequency.

Most popular intervention types in "Pima Vascular" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AURYON™ System" (1 trials), "Atherectomy" (1 trials) and "Dexamethasone Sodium Phosphate Injection, USP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pima Vascular" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Pima Vascular". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pima Vascular, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pima Vascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".